The DOI matches its Crossref record.
D1 receptor blockade stereospecifically impairs the acquisition of drug-conditioned place preference and place aversion
Abstract
The motivational effects of dopamine (DA) D1 receptor blockade and its influence on the motivational effects of amphetamine (1.0mg/kg s.c.), morphine (1.0mg/kg s.c.) and lithium (40mg/kg s.c.) were studied in a place-conditioning paradigm. Drugs tested were two potent D1 receptor antagonists, SCH 23390 and SCH 39166, that differ in the poor affinity of the latter for 5-HT(2) receptors, and SCH 23388, the inactive enantiomer of SCH 23390. SCH 23390 and SCH 39166, at low doses (12.5 and 25µg/kg s.c.), paired for 30min with one compartment, elicited place aversion. Higher doses of the D1 antagonists or pairing for 60min with one compartment failed to elicit place aversion. SCH 39166 (50µg/kg s.c.) paired with both compartments completely prevented the place-aversion elicited by SCH 23390 (12.5µg/kg s.c.). SCH 23390 and SCH 39166 at low doses (12.5 and 25µg/kg s.c. respectively), paired with both compartments, abolished amphetamine-induced place preference. The D1 antagonists also impaired the acquisition of morphine-induced place preference and lithium-induced place aversion but only at higher doses (50 and 100µg/kg s.c.). These effects were stereospecific as the inactive enantiomer SCH 23388, up to a dose of 500µg/kg s.c. failed to impair the acquisition of amphetamine and morphine-induced place preference. It is concluded that DA plays a dual role in motivation: one role is that of assigning motivational valence to stimuli in relation to changes in DA transmission; another role of DA relates to the learning process involved in the acquisition of positive as well as negative incentive properties by otherwise neutral stimuli (incentive learning).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Conditioning, driven by stimulation of D1 receptors in the nucleus accumbens, explains the addictive potential of drugs.
“Conditioning, driven by stimulation of D1 receptors in the nucleus accumbens, explains the addictive potential of drugs 47,48 .”
From Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention (2023) · cites this paper as [48]
Citations
Cited by
Sorted by citations
The mysterious motivational functions of mesolimbic dopamine
Salamone, J. D., & Correa, M. (2012) · Neuron · doi:10.1016/j.neuron.2012.10.021 · Cited by 1,418
Tzschentke, T. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00060-4 · Cited by 1,280
“Lithium chloride-induced CPA could also be prevented by naloxone, high doses of SCH 23390 and SCH 39166 (Acquas and Di Chiara, 1994), and radiofrequency lesions of the mediobasal arcuate hypothalamus, a precedure which markedly reduced the levels of b-endorphin in the hypothalamus.”
BackgroundMethodNucleus accumbens shell and core dopamine: differential role in behavior and addiction
Di Chiara, G. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00286-3 · Cited by 996
Role of dopamine in the behavioural actions of nicotine related to addiction
Chiara, G. D. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00122-9 · Cited by 697
Self-citationThe role of dopamine in drug abuse viewed from the perspective of its role in motivation
Chiara, G. D. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(95)01118-i · Cited by 639
Self-citationDrug addiction as dopamine-dependent associative learning disorder
Chiara, G. D. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00372-6 · Cited by 607
Self-citationVolkow, N. D., & Blanco, C. (2023) · World psychiatry · doi:10.1002/wps.21073 · Cited by 503
A motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug use
Chiara, G. D. (1998) · Journal of Psychopharmacology · doi:10.1177/026988119801200108 · Cited by 352
Self-citationDopamine D1-like Receptors and Reward-related Incentive Learning
Beninger, R. J. (1998) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(97)00019-5 · Cited by 299
“Di Chiara and coworkers showed that place conditioning with morphine was blocked by acute SCH 23390 or SCH 39166 (1,60).”
BackgroundResultThe biological, social and clinical bases of drug addiction: commentary and debate
Altman, J. S., Everitt, B. J., Robbins, T. W., Glautier, S., Markou, A., Nutt, D., Oretti, R. G., & Phillips, G. D. (1996) · Psychopharmacology · doi:10.1007/bf02246016 · Cited by 271
Chiara, G. D., Loddo, P., & Tanda, G. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00236-x · Cited by 262
Self-citationDI CHIARA, G., TANDA, G., BASSAREO, V., PONTIERI, F., ACQUAS, E., FENU, S., CADONI, C., & CARBONI, E. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09283.x · Cited by 242
Self-citationSellings, L. H. L., & Clarke, P. B. S. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-15-06295.2003 · Cited by 238
Dopamine receptors—physiological understanding to therapeutic intervention potential
Emilien, G. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00029-7 · Cited by 230
Tanda, G., & Chiara, G. D. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00135.x · Cited by 200
Self-citationWenzel, J. M., & Cheer, J. F. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.126 · Cited by 161
Manzanedo, C., Aguilar, M. A., Rodríguez‐Arias, M., & Miñarro, J. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00164-4 · Cited by 139
Effects of risperidone and SCH 23390 on isolation-induced aggression in male mice
Rodríguez‐Arias, M., Miñarro, J., Aguilar, M. A., Pinazo, J. M., & SIMON, V. M. (1998) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(97)00051-5 · Cited by 137
Xi, Z., Gilbert, J. G., Pak, A. C., Ashby, C. R., Heidbreder, C. A., & Gardner, E. L. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04159.x · Cited by 134
Nader, K., & van der Kooy, D. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-01-00383.1997 · Cited by 134
Fenu, S., Bassareo, V., & Chiara, G. D. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-17-06897.2001 · Cited by 128
Self-citationGABAergic MECHANISMS OF OPIATE REINFORCEMENT
Xi, Z. (2002) · Alcohol and Alcoholism · doi:10.1093/alcalc/37.5.485 · Cited by 127
Rezayof, A., Zarrindast, M., Sahraei, H., & Haeri-Rohani, A. (2003) · Journal of Psychopharmacology · doi:10.1177/0269881103174005 · Cited by 109
NEUROBIOLOGICAL CONSTRAINTS ON BEHAVIORAL MODELS OF MOTIVATION
Nader, K., Bechara, A., & van der Kooy, D. (1997) · Annual Review of Psychology · doi:10.1146/annurev.psych.48.1.85 · Cited by 108
Laviolette, S. R., Nader, K., & van der Kooy, D. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00327-8 · Cited by 105
Fenu, S., Spina, L., Rivas, E., Longoni, R., & Di Chiara, G. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0415-2 · Cited by 103
Spina, L., Fenu, S., Longoni, R., Rivas, E., & Di Chiara, G. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0211-4 · Cited by 102
Bassareo, V., Tanda, G., Petromilli, P., Giua, C., & Chiara, G. D. (1996) · Psychopharmacology · doi:10.1007/bf02247433 · Cited by 93
Self-citationMa, Y., Guo, C., Yu, P., Lee, D. Y. W., Han, J., & Cui, C. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.02.117 · Cited by 89
Besheer, J., Jensen, H. C., & Bevins, R. A. (1999) · Behavioural Brain Research · doi:10.1016/s0166-4328(99)00021-2 · Cited by 87
Effects of oil intake in the conditioned place preference test in mice
Imaizumi, M., Takeda, M., & Fushiki, T. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02416-1 · Cited by 87
Wright, J. M., Dobosiewicz, M., & Clarke, P. B. S. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2871-1 · Cited by 83
Graham, D. L., Hoppenot, R. G., Hendryx, A., & Self, D. W. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0473-5 · Cited by 79
Chiara, V. D., Errico, F., Musella, A., Rossi, S., Mataluni, G., Sacchetti, L., Siracusano, A., Castelli, M., Cavasinni, F., Bernardi, G., et al. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.141 · Cited by 82
Papp, M. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00349-4 · Cited by 78
Zarrindast, M., Rezayof, A., Sahraei, H., Haeri-Rohani, A., & Rassouli, Y. (2003) · Brain Research · doi:10.1016/s0006-8993(02)04201-4 · Cited by 76
The nucleus accumbens in reward and aversion processing: insights and implications
Xu, Y., Lin, Y., Yu, M., & Zhou, K. (2024) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2024.1420028 · Cited by 85
“Notably, evidence also points to D1 receptors playing a role in aversion processing (Acquas and Di Chiara, 1994; Chartoff et al., 2006; Kim et al., 2007), supporting the multifaceted role of DA transmission in the NAc (Verharen et al., 2020).”
BackgroundBailey, C. P., O'Callaghan, M. J., Croft, A. P., Manley, S. J., & Little, H. J. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00146-0 · Cited by 66
Veeneman, M. M. J., Boleij, H., Broekhoven, M. H., Snoeren, E. M. S., Guitart‐Masip, M., Cousijn, J., Spooren, W. P. J. M., & Vanderschuren, L. J. M. J. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2095-1 · Cited by 63
“…the development of both cocaine-and morphine-induced CPP (cocaine: Cervo and Samanin 1995; Shippenberg and Heidbreder 1995; Baker et al. 1998; Nazarian et al. 2004; morphine: Leone and Di Chiara 1987; Shippenberg and Herz 1988; Acquas et al. 1989; Acquas and Di Chiara 1994; Manzanedo et al. 2001).”
Collier, A. D., & Echevarria, D. J. (2013) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e328363d14a · Cited by 55
The Neurobiology of Ethanol‐Opioid Interactions in Ethanol Reinforcement
Froehlich, J. C., & Wand, G. S. (1996) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb01772.x · Cited by 53
Giorgi, O., Corda, M. G., Carboni, G., Frau, V., Valentini, V., & Chiara, G. D. (1997) · Behavior Genetics · doi:10.1023/a:1021405031412 · Cited by 53
“Thus, there is evidence that accumbal D1 DA receptor-mediated neurotransmiss ion is critical for the expression of place preference and place aversion (Shippenberg et al., 1991; Acquas and Di Chiara, 1994; for review see Di Chiara, 1995).”
BackgroundSelf-citationA lateral hypothalamic D1 dopaminergic mechanism in conditioned taste aversion
Caulliez, R., Meile, M.-J., & Nicolaı̈dis, S. (1996) · Brain Research · doi:10.1016/0006-8993(96)00426-x · Cited by 52
Galaj, E., Ewing, S., & Ranaldi, R. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.03.020 · Cited by 51
Chiara, G. D., Tanda, G., Cadoni, C., Acquas, E., Bassareo, V., & Caronboni, E. (1997) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60911-4 · Cited by 50
Self-citationVidal‐Infer, A., Roger-Sánchez, C., Daza‐Losada, M., Aguilar, M. A., Miñarro, J., & Rodríguez‐Arias, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043107 · Cited by 47
“kg), blockade of DA D1 receptors induced place aversion, a result that is in line with the findings of both classic and more recent reports [49,50,51].”
ResultMa, Y., Yu, P., Guo, C., & Cui, C. (2010) · Neurochemical Research · doi:10.1007/s11064-010-0342-9 · Cited by 48
“31966 block the acquisition of place preferences conditioned with psychostimulants, morphine or nicotine [1, 2].”
BackgroundBorgkvist, A., Usiello, A., Greengard, P., & Fisone, G. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301321 · Cited by 47
Chronic Cocaine Prevents Depotentiation at Corticostriatal Synapses
Centonze, D., Costa, C., Rossi, S., Prosperetti, C., Pisani, A., Usiello, A., Bernardi, G., Mercuri, N. B., & Calabresi, P. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.11.018 · Cited by 45
Behavioural Pharmacology and Neurobiology of Nicotine Reward and Dependence
Chiara, G. D. (2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57079-7_24 · Cited by 44
Self-citationCentonze, D., Rossi, S., Chiara, V. D., Prosperetti, C., Battista, N., Bernardi, G., Mercuri, N. B., Usiello, A., & Maccarrone, M. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05433.x · Cited by 38
Spina, L., Longoni, R., Vinci, S., Ibba, F., Peana, A. T., Muggironi, G., Spiga, S., & Acquas, E. (2010) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2009.01129.x · Cited by 37
Self-citationBassareo, V., Talani, G., Frau, R., Porru, S., Rosas, M., Kasture, S. B., Peana, A. T., Loi, E., Sanna, E., & Acquas, E. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00545 · Cited by 36
Self-citationScardochio, T., & Clarke, P. B. S. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2931-6 · Cited by 30
Endogenous opioids mediate basal hedonic tone independent of dopamine d-1 or d-2 receptor activation
Narayanan, S., Lam, H. A., Christian, L. J., Levine, M. S., Grandy, D. K., Rubinstein, M., & Maidment, N. T. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2003.11.011 · Cited by 31
Mohammadkhani, A., & Borgland, S. L. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24770 · Cited by 29
“Inhibition of μ opioid receptors in the VTA blocks CPP for opioids (Acquas & Chiara, 1994; Leone & Di Chiara, 1987), and μ agonist administration to the VTA promotes reward-seeking (Bozarth & Wise, 1981; Fields & Margolis, 2015).”
BackgroundPsychobiological Theories of Smoking and Smoking Motivation
Lujic, C., Reuter, M., & Netter, P. (2005) · European Psychologist · doi:10.1027/1016-9040.10.1.1 · Cited by 30
Longoni, R., Spina, L., Vinci, S., & Acquas, E. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2192-9 · Cited by 25
Self-citationHypocretin/Orexin Involvement in Reward and Reinforcement
España, R. A. (2012) · Vitamins and hormones · doi:10.1016/b978-0-12-394623-2.00010-x · Cited by 26
Analgesic, anti-inflammatory, and anti-pyretic activity1
Vogel, H. G., Vogel, W. H., Schölkens, B. A., Sandow, J., Müller, G. A., & Vogel, W. F. (2002) · Springer eBooks · doi:10.1007/3-540-29837-1_9 · Cited by 25
Rodgers, H. M., Yow, J., Evans, E., Clemens, S., & Brewer, K. L. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.03.034 · Cited by 25
Marotta, R., Fenu, S., Scheggi, S., Vinci, S., Rosas, M., Falqui, A., Gambarana, C., Montis, M. G. D., & Acquas, E. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00153 · Cited by 23
“Similarly, in agreement with the observation that DA D1 receptor antagonists prevent aversive learning (Acquas et al., 1989; Acquas and Di Chiara, 1994; Fenu et al., 2001), blockade of DA D1 receptors by systemic SCH 23390, as well as by local administration of SCH 39166 in the shell of the nucleus…”
ResultSelf-citationModulation of the Stimulus Effects of Morphine by d-Amphetamine
Gaiardi, M. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00371-7 · Cited by 22
Matsumura, S., Yoneda, T., Aki, S., Eguchi, A., Manabe, Y., Tsuzuki, S., Inoue, K., & Fushiki, T. (2010) · Physiology & Behavior · doi:10.1016/j.physbeh.2009.12.018 · Cited by 19
Sturgess, J. E., Ting‐A‐Kee, R. A., Podbielski, D. W., Sellings, L. H. L., Chen, J., & van der Kooy, D. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07247.x · Cited by 19
Katebi, N., Farahimanesh, S., Fatahi, Z., Zarrabian, S., & Haghparast, A. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.07.018 · Cited by 19
“In addition to being involved in the reward mechanism, dopamine also is a key player in motivation [48].”
Maccioni, R., Serra, M., Marongiu, J., Cottiglia, F., Maccioni, E., Bassareo, V., Morelli, M., Kasture, S. B., & Acquas, E. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06069-w · Cited by 17
Self-citationKobrin, K. L., Arena, D. T., Heinrichs, S. C., Nguyen, O. H., & Kaplan, G. B. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.01.011 · Cited by 17
Differential role of dopamine in drug- and lithium-conditioned saccharin avoidance
Fenu, S., Rivas, E., & DiChiara, G. (2005) · Physiology & Behavior · doi:10.1016/j.physbeh.2005.04.002 · Cited by 16
Dopaminergic signaling supports auditory social learning
Paraouty, N., Rizzuto, C. R., & Sanes, D. H. (2021) · Scientific Reports · doi:10.1038/s41598-021-92524-1 · Cited by 17
Ågmo, A., & Soria, P. (1999) · Journal of Neural Transmission · doi:10.1007/s007020050152 · Cited by 15
Masi, F., Leggio, B., Nanni, G., Scheggi, S., Montis, M. G. D., Tagliamonte, A., Grappi, S., & Gambarana, C. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300078 · Cited by 15
Repeated cocaine decreases the avoidance response to a novel aversive stimulus in rats
Sorg, B. A., Davidson, D. L., Hochstatter, T., & Sylvester, P. W. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1133-z · Cited by 14
Chiara, G. D. (2002) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-06765-9_10 · Cited by 13
Self-citationSpina, L., Longoni, R., Rosas, M., Collu, M., Peana, A. T., Espa, E., Kasture, S. B., Cotti, E., & Acquas, E. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115600132 · Cited by 12
Self-citationRole of nucleus accumbens μ opioid receptors in the effects of morphine on ERK1/2 phosphorylation
Rosas, M., Porru, S., Fenu, S., Ruiu, S., Peana, A. T., Papale, A., Brambilla, R., Chiara, G. D., & Acquas, E. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4340-8 · Cited by 12
Self-citationFenu, S., Rivas, E., & Chiara, G. D. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2008.08.017 · Cited by 11
Self-citationMiranda, M. I., Rangel-Hernández, J. A., Vera‐Rivera, G., Medina, N. E. G., Soto-Alonso, G., Rodríguez-García, G., & Núñez-Jaramillo, L. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.07.009 · Cited by 11
A Novel Perspective on Dopaminergic Processing of Human Addiction
Badgaiyan, R. D. (2013) · Journal of Alcoholism and Drug Dependence · doi:10.4172/2329-6488.1000e101 · Cited by 9
“These studies have demonstrated that blockade of D1 receptors prevents formation of an association between drug and its environment and its agonists enhance acquisition of conditioned response (16).”
BackgroundMarathe, P., Raut, S., Satam, S., Shetty, Y., Pooja, S., Raut, A., Kale, P., & Rege, N. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113304 · Cited by 6
Rosas, M., Porru, S., Sabariego, M., Piludu, M. A., Giorgi, O., Corda, M. G., & Acquas, E. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4740-4 · Cited by 9
Self-citationJaparin, R. A., Harun, N., Hassan, Z., & Müller, C. P. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114638 · Cited by 8
Chapter VI Dopamine, motivation and reward
Chiara, G. D. (2005) · Handbook of chemical neuroanatomy · doi:10.1016/s0924-8196(05)80010-7 · Cited by 7
Self-citationBiology of Motivation, Dopamine, and Brain Circuits That Mediate Pleasure
Freed, W. J. (2022) · Springer eBooks · doi:10.1007/978-3-031-10477-0_11 · Cited by 7
Cheng, C.-N., Kozłowska, A., Li, W.-L., Wu, C.-W., Wang, Y., & Huang, A. C. W. (2025) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2025.173957 · Cited by 5
Shahzadi, A., Yunusoğlu, O., Karabulut, E., Sönmez, H., & Yazıcı, Z. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.855241 · Cited by 5
“Many studies support that both naloxone-induced withdrawal and spontaneous opioid withdrawal symptoms decrease the dopamine level in brain reward centers (Acquas and Chiara, 1994; Crippens and Robinson, 1994; Shaham et al., 1996).”
BackgroundMolecular Pharmacology and Neuroanatomy
Acquas, E. (2000) · Handbooks of pharmacology and toxicology · doi:10.1201/9781420036961.ch34 · Cited by 2
Self-citationDrug-Addiction and Drug-Dependency
France, C. P. (2013) · Springer eBooks · doi:10.1007/978-3-642-25240-2_10 · Cited by 2
The dopamine release inhibitor CGS 10746B blocks conditioned physical signs of morphine withdrawal
Rodríguez‐Arias, M., Aguilar, M. A., & Miñarro, J. (2003) · Addiction Biology · doi:10.1080/1355621031000117392 · Cited by 2
Side Effects of Central Analgesic Drugs
Arendt‐Nielsen, L. (2013) · Springer eBooks · doi:10.1007/978-3-642-25240-2_15
SegregationofAmphetamineRewardandLocomotor StimulationbetweenNucleusAccumbensMedialShelland Core
LaurieH, L., & Clarke, S. (2003)
Dopamine D1 and D3 Receptor Polypharmacology in Cocaine Reward and Cocaine Seeking
Galaj, E. (2017) · CUNY Academic Works (City University of New York)
Nawaz, S. (2011) · TSpace (University of Toronto)
Nguyen, D. P. (2018) · TSpace (University of Toronto)
Side Effects of Central Analgesic Drugs
France, C. P. (2006) · Springer eBooks · doi:10.1007/3-540-29804-5_10
Opioid Reinforcement: What It Is And How It Can Be Modulated By Cannabinoids
Cadoni, C. (2022) · Springer eBooks · doi:10.1007/978-3-030-67928-6_98-1
Opioid Reinforcement: What It Is and How It Can Be Modulated by Cannabinoids
Cadoni, C. (2022) · Springer eBooks · doi:10.1007/978-3-030-92392-1_98
Neurotransmitters and Neural Pathways
Schnall, J. S. (2026) · Springer eBooks · doi:10.1007/978-3-031-57159-6_33-1
Metadata
- Authors
- Acquas, E., & Chiara, G. D.
- Affiliations
- University of Cagliari (IT)
- Corresponding author
- Chiara, G. Di
- ORCID
- Acquas, E.
- Venue
- Behavioural Pharmacology
- Published
- 1994-10
- Volume
- 5
- Issue
- 6
- Pages
- 555-569
- ISSN
- 0955-8810 (ISSN-L)
- OpenAlex
- W2088891858
- Cited by
- 98
- References
- 0
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 2 · 2022: 5 · 2021: 1 · 2020: 2 · 2019: 2 · 2018: 3 · 2017: 5 · 2016: 1 · 2015: 1 · 2014: 1 · 2013: 4 · 2012: 5
- FWCI
- 1.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Behavioural Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- dopamine D1 receptor, dopamine D1 receptor antagonist, stereospecificity, place conditioning, place preference, place aversion, amphetamine, morphine, lithium, incentive learning, SCH 23390, SCH 39166, enantiomers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review